Value investing has produced some of the world’s most famous investing billionaires, including Warren Buffett, David Einhorn, and Seth Klarman, who built their fortunes by purchasing wonderful businesses at reasonable prices. But these hidden gems are few and far between - many stocks that appear cheap often stay that way because they face structural issues.
Separating the winners from the value traps is a tough challenge, and that’s where StockStory comes in. Our job is to find you high-quality companies that will stand the test of time. That said, here are three value stocks with poor fundamentals and some alternatives you should consider instead.
Amphastar Pharmaceuticals (AMPH)
Forward P/E ratio: 8.1x
Founded in 1996 and known for its expertise in complex drug formulations, Amphastar Pharmaceuticals (NASDAQ: AMPH) develops and manufactures technically challenging injectable and inhalation medications, including both generic and proprietary pharmaceutical products.
Why Does AMPH Worry Us?
- Annual revenue growth of 1.2% over the last two years was below our standards for the healthcare sector
- Revenue base of $730 million puts it at a disadvantage compared to larger competitors exhibiting economies of scale
- Efficiency has decreased over the last two years as its adjusted operating margin fell by 12.7 percentage points
At $26.97 per share, Amphastar Pharmaceuticals trades at 8.1x forward P/E. Dive into our free research report to see why there are better opportunities than AMPH.
Ladder Capital (LADR)
Forward P/B ratio: 0.8x
Founded during the 2008 financial crisis when traditional lenders retreated from commercial real estate, Ladder Capital (NYSE: LADR) is a real estate investment trust that originates commercial real estate loans, owns commercial properties, and invests in real estate securities.
Why Are We Cautious About LADR?
- Products and services are facing significant end-market challenges during this cycle as sales have declined by 8.1% annually over the last two years
- Earnings per share decreased by more than its revenue over the last two years, showing each sale was less profitable
- Products and services are facing profitability challenges during this cycle, as seen in its flat tangible book value per share over the last five years
Ladder Capital is trading at $9.35 per share, or 0.8x forward P/B. Read our free research report to see why you should think twice about including LADR in your portfolio.
Kosmos Energy (KOS)
Forward P/E ratio: 5x
Operating in some of the world's deepest waters with projects located up to 120 kilometers offshore, Kosmos Energy (NYSE: KOS) explores for, develops, and produces oil and natural gas from deepwater offshore fields.
Why Are We Wary of KOS?
- Muted 8.4% annual revenue growth over the last five years shows its demand lagged behind its energy upstream and integrated energy peers
- Costs have risen faster than its revenue over the last five years, causing its EBITDA margin to decline by 10.5 percentage points
- Cash burn makes us question whether it can achieve sustainable long-term growth
Kosmos Energy’s stock price of $2.78 implies a valuation ratio of 5x forward P/E. To fully understand why you should be careful with KOS, check out our full research report (it’s free).
High-quality stocks for all market conditions
ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time.
Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+1,154% between June 2020 and June 2025). Find your next big winner with StockStory today.
